Top compounds associated with response to CEBPG


Feature Type Standardized
Nominal ANOVA
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 6e-08
mRNA KW-2449 CTRPv2 pan-cancer AAC 0.17 8e-08
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA vincristine CTRPv2 pan-cancer AAC 0.16 4e-07
mRNA FK866 GDSC1000 pan-cancer AAC 0.16 5e-07
mRNA indisulam CTRPv2 pan-cancer AAC 0.16 1e-06
mRNA CD-437 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA Axitinib CTRPv2 pan-cancer AAC 0.16 5e-06
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC 0.14 5e-06
Download CSV